AstraZeneca Defends Dosing Error in Covid-19 Vaccine Trial 
 

A top AstraZeneca executive pushes back against criticism that the company failed to disclose enough data from a clinical trial of its Covid-19 vaccine.

 
Facebook's Latest Error Shakes Advertisers' Confidence 
 

The company quietly told advertisers this month that its "conversion lift" tool, used to measure outcomes, overestimated some campaign results.

 
TikTok Granted Extension on Divestiture Order 
 

Federal officials have granted TikTok and its Chinese parent ByteDance a weeklong extension of a deadline for completing a divestiture deal, in another delay of the Trump administration's effort to turn the social-media app into an American company.

 
Salesforce Is in Talks to Acquire Slack Technologies 
 

A deal, which would mark a big move by the corporate-software maker into office communications, could be reached in days.

 
Justice Department Clears Intuit to Buy Credit Karma 
 

Antitrust officials cleared Credit Karma's pending $7.1 billion sale to TurboTax maker Intuit after the two companies agreed to divest Credit Karma's burgeoning tax-preparation business.

 
Walmart, Grocers Can Avoid New Mexico Shutdowns With Covid-19 Testing 
 

State officials in New Mexico are offering grocery stores, retailers and other essential businesses a way to avoid shutdowns when workers become infected with Covid-19: regularly test all employees.

 
Amazon Web Services Hit by Outage 
 

The company said it was experiencing errors that were causing issues for a range of cloud-software programs in its region covering the eastern part of the U.S.

 
Delta, Pilots Strike Deal to Save Jobs 
 

Pilots agreed to accept reduced pay in exchange for job security until 2022, as the industry continues to grapple with reduced travel demand due to the pandemic.

 
GE Appliances Turns Up the Speed on Supply-Chain Upgrade 
 

Coronavirus-driven disruptions in demand and production added urgency to a GE Appliances digital supply-chain upgrade aimed at building visibility and flexibility.

 
China Drugmakers Face Pressure to Prove Their Covid-19 Vaccines Work 
 

Pressure is mounting on Chinese drugmakers to show clinical evidence that their leading Covid-19 vaccines work, after early data on three Western-developed shots showed promising effectiveness against the disease.

 
 

(END) Dow Jones Newswires

November 25, 2020 23:15 ET (04:15 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.